AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Robinson, C Callow, M Stevenson, S Robinson, BWS Lake, RA
Citation: C. Robinson et al., Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis, RESPIR RES, 2(2), 2001, pp. 119-124

Authors: Robinson, BWS Scott, BM Lake, RA Stumbles, PA Nelson, DJ Fisher, S Marzo, AL
Citation: Bws. Robinson et al., Lack of ignorance to tumor antigens: Evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis - Implications for tumor tolerance, CLIN CANC R, 7(3), 2001, pp. 811S-817S

Authors: McLaren, BR Whitaker, D Robinson, BWS Lake, RA
Citation: Br. Mclaren et al., Expression and integrity of DNA topoisomerase II isoforms does not explaingeneric drug resistance in malignant mesothelioma, CANC CHEMOT, 48(1), 2001, pp. 1-8

Authors: Robinson, BWS Robinson, C Lake, RA
Citation: Bws. Robinson et al., Localised spontaneous regression in mesothelioma - possible immunological mechanism, LUNG CANC, 32(2), 2001, pp. 197-201

Authors: Creaney, J McLaren, BM Stevenson, S Musk, AW de Klerk, N Robinson, BWS Lake, RA
Citation: J. Creaney et al., p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression, BR J CANC, 84(1), 2001, pp. 52-56

Authors: Robinson, C Callow, M Stevenson, S Scott, B Robinson, BWS Lake, RA
Citation: C. Robinson et al., Serologic responses in patients with malignant mesothelioma - Evidence forboth public and private specificities, AM J RESP C, 22(5), 2000, pp. 550-556

Authors: Mukherjee, S Haenel, T Himbeck, R Scott, B Ramshaw, I Lake, RA Harnett, G Phillips, P Morey, S Smith, D Davidson, JA Musk, AW Robinson, B
Citation: S. Mukherjee et al., Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: Persistent transgene expression despite antibody generation, CANC GENE T, 7(5), 2000, pp. 663-670

Authors: Hayball, JD Lake, RA
Citation: Jd. Hayball et Ra. Lake, Altered superantigenic ligands demonstrate the quantitative nature of T-cell activation, IMM CELL B, 78(6), 2000, pp. 623-632

Authors: Hayball, JD Lake, RA
Citation: Jd. Hayball et Ra. Lake, Partial T cell activation with an altered superantigenic ligand, IMM CELL B, 78(1), 2000, pp. 13-19

Authors: McLaren, BR Robinson, BWS Lake, RA
Citation: Br. Mclaren et al., New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production, CANC CHEMOT, 45(6), 2000, pp. 502-508

Authors: Marzo, AL Kinnear, BF Lake, RA Frelinger, JJ Collins, EJ Robinson, BWS Scott, B
Citation: Al. Marzo et al., Tumor-specific CD4(+) T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity, J IMMUNOL, 165(11), 2000, pp. 6047-6055

Authors: McLaren, BR Haenel, T Stevenson, S Mukherjee, S Robinson, BWS Lake, RA
Citation: Br. Mclaren et al., Simian virus (SV) 40 like sequences in cell lines and tumour biopsies fromAustralian malignant mesotheliomas, AUST NZ J M, 30(4), 2000, pp. 450-456

Authors: Robinson, BWS Lake, RA Nelson, DJ Scott, BA Marzo, AL
Citation: Bws. Robinson et al., Cross-presentation of tumour antigens: Evaluation of threshold, duration, distribution and regulation, IMM CELL B, 77(6), 1999, pp. 552-558

Authors: Lake, RA Robinson, BWS Hayball, JD
Citation: Ra. Lake et al., MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response, IMM CELL B, 77(1), 1999, pp. 99-104

Authors: Marzo, AL Lake, RA Lo, D Sherman, L McWilliam, A Nelson, D Robinson, BWS Scott, B
Citation: Al. Marzo et al., Tumor antigens are constitutively presented in the draining lymph nodes, J IMMUNOL, 162(10), 1999, pp. 5838-5845

Authors: Marzo, AL Lake, RA Robinson, BWS Scott, B
Citation: Al. Marzo et al., T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors, CANCER RES, 59(5), 1999, pp. 1071-1079
Risultati: 1-16 |